| SLRX Stock | | | USD 1.37 0.09 6.16% |
Salarius Pharmaceuticals financial indicator trend analysis is much more than just breaking down Salarius Pharmaceuticals prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Salarius Pharmaceuticals is a good investment. Please check the relationship between Salarius Pharmaceuticals Begin Period Cash Flow and its Capital Expenditures accounts. Check out
World Market Map to better understand how to build diversified portfolios, which includes a position in Salarius Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in metropolitan statistical area.
For more information on how to buy Salarius Stock please use our
How to Invest in Salarius Pharmaceuticals guide.
Begin Period Cash Flow vs Capital Expenditures
Begin Period Cash Flow vs Capital Expenditures Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of
Salarius Pharmaceuticals Begin Period Cash Flow account and
Capital Expenditures. At this time, the significance of the direction appears to have fragmental relationship.
The correlation between Salarius Pharmaceuticals' Begin Period Cash Flow and Capital Expenditures is 0.46. Overlapping area represents the amount of variation of Begin Period Cash Flow that can explain the historical movement of Capital Expenditures in the same time period over historical financial statements of Salarius Pharmaceuticals, assuming nothing else is changed. The correlation between historical values of Salarius Pharmaceuticals' Begin Period Cash Flow and Capital Expenditures is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Begin Period Cash Flow of Salarius Pharmaceuticals are associated (or correlated) with its Capital Expenditures. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Capital Expenditures has no effect on the direction of Begin Period Cash Flow i.e., Salarius Pharmaceuticals' Begin Period Cash Flow and Capital Expenditures go up and down completely randomly.
Correlation Coefficient | 0.46 |
| Relationship Direction | Positive |
| Relationship Strength | Weak |
Begin Period Cash Flow
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.
Capital Expenditures
Capital Expenditures are funds used by Salarius Pharmaceuticals to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Salarius Pharmaceuticals operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.
Most indicators from Salarius Pharmaceuticals' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Salarius Pharmaceuticals current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out
World Market Map to better understand how to build diversified portfolios, which includes a position in Salarius Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in metropolitan statistical area.
For more information on how to buy Salarius Stock please use our
How to Invest in Salarius Pharmaceuticals guide.
Issuance Of Capital Stock is likely to rise to about 10.1
M in 2024, whereas
Selling General Administrative is likely to drop 5,435 in 2024.
Salarius Pharmaceuticals fundamental ratios Correlations
Click cells to compare fundamentals
Salarius Pharmaceuticals Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Salarius Pharmaceuticals fundamental ratios Accounts
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Additional Tools for Salarius Stock Analysis
When running Salarius Pharmaceuticals' price analysis, check to
measure Salarius Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Salarius Pharmaceuticals is operating at the current time. Most of Salarius Pharmaceuticals' value examination focuses on studying past and present price action to
predict the probability of Salarius Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Salarius Pharmaceuticals' price. Additionally, you may evaluate how the addition of Salarius Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.